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Abstract— Type 1 Patients with Diabetes (Type 1 PwDs)
have to frequently adjust their insulin dosage to keep their
Blood Glucose concentration (BG) within normal bounds. Meal
intakes represent the most important disturbance that has
to be accounted for. Its effect differs for every individual as
well as for every meal. These specificities are automatically
taken into account in the approach proposed in this paper.
Model parameters are identified for every couple (Patient,
Meal) of interest and optimal control is applied to generate
individualized meal specific insulin profiles. The method does
not require the use of a continuous BG meter, the profiles being
infused in an open-loop manner. Results from a preliminary
clinical study are presented. The concept is shown to be
effective, despite limitations due to the aggressive execution
chosen. Improvements are proposed and a possible pratical
implementation is described.
I. INTRODUCTION
It has been shown that a high average Blood Glucose
concentration (BG) over several years increases the risk of
severe long term complications, among them nephropathy,
retinopathy, cardiovascular diseases or renal failure [1]. On
the other hand, too much insulin can lead to a hypoglycemic
event, which is a potentially lethal condition.
Type 1 Patients with Diabetes (Type 1 PwDs) have to
compensate for events that can be perceived as disturbances
from a control point of view. Meal intakes, physical activity
[2], stress [3] or menstrual cycles belong to the set of
disturbances that have to be accounted for by Type 1 PwDs
in their insulin dosage.
Optimized BG control after meal intake has a high po-
tential for improving the treatment of Type 1 PwDs. During
the day, the BG depends mainly on the quality of the meal
compensations. However, this task is also very challenging
because the patient as well as the meal specificities have to
be accounted for.
Today, most of the Type 1 PwDs estimate their insulin
boluses based on the carbohydrate content of the meal and
the measured BG at meal time. They typically infuse this
bolus just before the meal intake. One of the main limitations
of this strategy lies in the fact that only carbohydrate content
is considered, while each meal has its own specificity and
can lead to very different BG profiles. Typical BG excursions
are shown in Fig. 1. These measurements were taken for
the same patient at two consecutive days, at the same
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Fig. 1. Postpandrial glucose excursions after a fast and a slow meal for
the same patient, meal carbohydrate content, and insulin bolus
daytime, with the same insulin bolus, and with equal meal
carbohydrate content but different meal compositions. For
the so-called fast meals (mainly carbohydrate content), a high
glucose peak is measured approximately 45 minutes after the
meal intake. After this peak, the BG decreases very abruptly.
Very often, an intervention is needed to compensate for
the resulting low BGs. The BG excursion measured for the
slow meal (important fat and protein content) is completely
different: no peak but a drop followed by a slow and large
increase, is observed. BG remains high several hours after
the meal intake. This clearly shows that the standard one-shot
carbohydrate based insulin bolus cannot handle variations
of meal contents, which limits the efficiency of most bolus
calculators [4].
The delivery of exogenous insulin has undergone signif-
icant changes with the introduction of the insulin pump, a
device that allows continuous infusion of fast acting insulin.
Nowadays, most pumps are equipped with ”smart” meters.
These meters have increased computational capacities and
can exchange data with insulin pumps. With such devices, the
one-shot meal insulin bolus can be replaced by a distributed
insulin infusion profile. It makes it possible to shape the
profiles and adapt them to the specificity of each meal. This
possibility has barely been used so far, and is the topic of
this paper.
Today, the research focus is on closed-loop control aim-
ing at a so-called Artificial Pancreas (AP). Two different
types of controllers are considered, either a pure feedback
controller [5], or model predictive controllers (MPC) [6],
[7]. These closed-loop approaches require continuous BG
measurements, which are provided by a Continuous Subcu-
taneous Glucose Monitor (CGM). Such sensors suffer from
severe limitations, among them reduced accuracy, potential
sensor drop-outs or time delays of approximately 20 minutes.
Important safety issues related to the automatically changing
insulin infusion generated by an AP are another drawback.
All these limitations preclude the use of closed-loop con-
trollers, for the time being.
For this reason, an open-loop optimal control strategy is
proposed. It does not require the use of a CGM, but it
could be extended to use continuous measurements. The
strategy provides meal specific distributed insulin profiles.
These may be inspected for their safety before the infusion.
Patient and meal specific model parameters are identified that
are subsequently used to compute optimal insulin infusion
profiles. The effectiveness of this method is evaluated in
a preliminary clinical study, where BG is monitored and
compared to BG excursions shown in Fig. 1, for the same
two-meal scenario.
This paper is organized as follows: In section II, the
proposed approach is detailed and the model, the parameter
identification strategy and the optimal control problem are
explained. A possible implementation using existing devices
is also sketched in this section. In section III, clinical results
are presented and discussed. Finally, in section IV, conclu-
sions are drawn and possible improvements are sketched.
II. METHODS
A. Modeling
The optimal control approach chosen in this work requires
a dynamical model of the system. The minimal model, see
[8], has been extended to account for a subcutaneous insulin
infusion and an oral meal intake. The insulin action and
absorption submodel have then been simplified to improve
the identifiability of the parameters. The resulting model is
given in (1) to (6).
dUg,gut(t)
dt
= U˙g,gut(t) (1)
dU˙g,gut(t)
dt
= −2agU˙g,gut(t)− a2gUg,gut(t) +Kga2gUcho(t)
(2)
dQ(t)
dt
= −X(t)Q(t)− Sg,zeroQ(t) + Uendo
+
Cg→mmol
M
Ug,gut(t) (3)
dX(t)
dt
= −axX(t) + axX1(t) (4)
dX1(t)
dt
= −axX1(t) +KxaxUi,sq(t)
M
(5)
G(t) =
Q(t)
Vga
, (6)
where the states are the gut glucose absorption Ug,gut
in g/min, the time derivative of the gut glucose absorption
U˙g,gut in g/min/min, the glucose amount Q in mmol/kg,
the insulin action X in min−1, and the intermediate insulin
action X1 in min−1.
Model parameters are the patient’s body weight M in kg,
the volume of the accessible compartment per body mass Vga
in L/kg, the unitless bioavailability of the meal of interest Kg ,
the inverse of the time constant of the meal of interest ag in
min−1, the insulin sensitivity Kx in kg/mU, the inverse of the
time constant of the insulin absorption/action ax in min−1,
the glucose effectiveness at zero insulin Sg,zero in min−1,
and the insulin independent endogenous glucose production
Uendo in mmol/kg/min. Cg→mmol converts g of glucose into
mmol.
The only manipulated variable is the subcutaneous insulin
infusion, Ui,sq(t) in mU/min, and the output is the BG G(t)
in mg/dL. The carbohydrate intake rate Ucho(t) in g/min can
be viewed as a predictable disturbance.
The model equations (1) to (6) can be expressed with the
compact equation x˙ = f(x, u, v,θ) where x is the vector
of states, u the manipulated input Ui,sq , v the predictable
disturbance Ucho, and θ represents the vector of model
parameters.
Values for Cg→mmol and M are known or can be mea-
sured directly, while Kg , ag , Kx, ax, Sg,zero, and Uendo have
to be identified. Vga can be assumed constant and equal to
the population mean [9]. Therefore, the vector of parameters
to identify is θid = [Kg ag Kx ax Sg,zero Uendo]
T .
B. Parameter identification
The model parameters have to be computed for each
couple (patient = P , meal = A) as individualized meal
specific insulin recommendations are looked for. Therefore,
for each meal to be controlled with the proposed approach,
corresponding patient BG measurements, with a maximum
sampling time of about 1 hour (for example Fig. 5), are
needed around the meal time. These measurements can be
performed with a classical strip-based meters and do not
require the use of a CGM.
These data are exploited to compute the parameter values
θid,∗P,A for the couple (P , A) that minimize a Maximum A
Posteriori (MAP) criterion. The necessary a priori knowl-
edge can be computed using experimental data through a
population-based approach, like for example the Iterative
Two Stage (ITS) method described by [10], or it can be
deduced from available knowledge on the physiology (meal
absorption, insulin kinetics). The simple model structure
together with the use of a priori knowledge lead to an identifi-
ability with parameters’ coefficients of variation below 100%
(cf [11]).
For a MAP identification, illustrated in Fig. 2, the follow-
ing optimization problem is solved.
M∗ = arg min Jid(M) (7)
s.t. Jid(M) =
Ng∑
i=1

(
Gˆ(ti,θ
id
P,A, v, u)−G(ti)
)2
σ2i

+
Nθ∑
j=1
M2j
θidP,A = exp(AM +B),
where G(ti) are the Ng glucose measurements used for
the identification. Measurement errors are supposed to be
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Fig. 2. MAP parameter identification
normally distributed and σi are the corresponding standard
deviations. Gˆ(ti,θidP,A, v, Ui,sq) are model predictions, Nθ is
the number of parameters to identify, and Mj are the Nθ
normalized Gaussian variables described in the Appendix.
C. Optimal profile generation
Once the parameters have been identified for a couple (P,
A), a model-based optimal control problem is solved. The
manipulated input, i.e. the subcutaneously infused insulin
Ui,sq , is parameterized with a piecewise constant function
with constant sampling time T . The control horizon is
defined by the start time th,s and the end time th,e.
With such an input parameterization, Ui,sq(t) = U(pi),
∀t ∈ [th,s, th,e], i.e. Ui,sq(t) can be generated using a
vector of scalar parameters pi =
[
pi1 . . . piNpi
]T
, which
corresponds to a sequence of infusion rates. Npi is the number
of sampling intervals for the period [th,s, th,e]. Thus, the
optimization problem reads:
pi∗ = arg min Jopt(pi) (8)
s.t. Jopt(pi) =
∫ th,e
th,s
(
Gˆ(t,θid,∗P,A, v,pi)−Gtg,A(t)
)2
dt
0 ≤ pi ≤ pimax,
As seen, the square of the difference between a meal de-
pendent target profile Gtg,A(t) for meal A and the predicted
blood glucose concentration Gˆ(t) is minimzed. pimax is the
insulin pump’s maximum infusion rate.
The target profiles for the two meals of interest in the
preliminary clinical study are plotted in Fig. 6.
Patient’s BG measurement at time th,s as well as informa-
tion on infused insulin before th,s are used to compute the
values of the model states at th,s. Therefore, the computed
optimized insulin profile will automatically correct for an
initially too low or too high BG. It will also account for the
pre-meal insulin infusion history (so called insulin on board),
as illustrated in Fig. 3.
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Fig. 3. Overview of the optimization process
D. Practical implementation
A possible implementation strategy of this method is
sketched in this section.
Today, some insulin pumps are coupled to a ”smart” meter.
The Accu-Chek R© Combo system from Roche is a good
example. The glucose meter has been extended and offers
additional functionalities. It communicates with the pump
and can be used to program a bolus or change the basal rate.
On the clinician side, a data management software like Accu-
Chek R© 360◦ can be used to collect and process the patient
data from the pump and meter. The Accu-Chek R© Combo
together with the software Accu-Chek R© 360◦ is used as an
example for the implementation of the method proposed in
this article.
The implementation is divided in 4 main steps. They are
described in what follows and are illustrated in Fig. 4.
1) Based upon his BG history, the PwD and his Health
Care Provider (HCP) identify the meals that have been
badly controlled since the last visit. Among these
”problematic meals”, those who can be potentially
improved by the method presented in this paper are
selected. The HCP data management software is used
to assist the HCP in the selection process. A BG
measurement schedule as well as the list of problematic
meals are uploaded to the PwD’s smart meter.
2) The PwD will follow this BG measurement schedule
(e.g. in Fig. 5) for the selected meals. A reminder is
implemented in the smart meter to ensure compliance
with this schedule. The data collected during theses
sequences are stored in the smart meter.
3) During the PwD’s next visit to his HCP, model pa-
rameters values are identified as shown in II-B for the
meals for which the BG measurement schedule has
been followed. The computed model parameters are
uploaded to the smart meter which is able to perform
insulin profile optimization. Typically, the identifica-
tion strategy is implemented as a module of the HCP
data management software. In Fig. 4, it is assumed that
the model parameters have been computed for the two
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meals A and B.
4) The next time one of these two meals is eaten, the
PwD’s smart meter computes an optimal insulin pro-
file, on the basis of the pre-meal BG, the insulin
infusion history, and the identified model parameters
for this meal as described in 4. The resulting profile is
automatically injected by the insulin pump.
It should be noted that the PwD’s safety is of highest
importance and needs to be guaranteed before any out-patient
implementation.
III. PRELIMINARY CLINICAL STUDY
A. Study design
A clinical study was performed to test the proposed
method on 12 Type 1 PwDs. Both fast and slow meals, as
depicted in Fig. 1, were considered. For conciseness reasons,
only results for 2 patients are discussed.
During the first in-patient period, referred to as ”first
block”, the patients had to eat the two meals on two
consecutive days at 9:00 a.m. and to control their BG using
the standard therapy. As illustrated in Fig. 5, eight different
BG measurements were made around the meal intake with a
sampling time of 1h. The first one was made 1 hour before
the meal intake and the last one 7 hours after. The dataset
was used to identify the parameters for each couple (P, A)
using the strategy discussed in subsection II-B. The a priori
knowledge was generated using ITS (cf II-B). σi has been
chosen independent of the model and equal to 0.05G(ti).
This describes the assumption that glucose measurements
Meal Intake
6 [h]1 [h]
Glucose measurements
Fig. 5. BG measurement schedule
Fig. 6. Glucose target profiles
exhibit a standard deviation equal to 5 % of the measured
glucose value. This value is of particular importance when
the number of measurements is low and the weight of the
Bayesian term in the objective function is not negligible.
The second in-patient period, referred to as ”second
block”, took place approximately 2 months after the first
one. During this period, the optimization routine described
in subsection II-C was used to compute optimized insulin
profiles. th,s was set to 1 hour before meal intake and th,e
to 6 hours after meal intake. A sampling period T of 10
min was fixed. This led to Npi = 42 decision variables to
optimize. The two target profiles depicted in Fig. 6 were used
for the fast and slow meals. It can be noted that these target
profiles exhibit similar shapes, but the peak of the profile
used for the slow meal is shifted by an hour. The resulting
optimized insulin profiles were infused to the patients, while
their BG was measured every 10 min from intravenous blood
draws to assess the performances of the proposed approach.
B. Study results
The results of the study for the two patients are shown
in Fig. 7 to 10. On the left hand side, the infused insulin
profiles for the two blocks are plotted. The green and the
blue curves represent the one-shot boluses and the optimal
insulin profiles, respectively. On the right hand side, the BG
excursions measured in the two blocks are plotted. The green
and blue lines represent the measured BGs in the first and
second block, respectively. The dotted blue line gives the
expected BG excursion for the second block. The prediction
capabilities of the model can be studied by comparing the
plain blue line with the dotted blue line.
Similar conclusions can be drawn for the two patients.
At the beginning of the optimization horizon (before meal
intake), the optimization computed large insulin amounts.
It can be seen in the four figures that these corrections
were efficient. For the fast meals, this large initial amount
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Fig. 7. Clinical results, patient 1, fast meal
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Fig. 8. Clinical results, patient 1, slow meal
also compensates for the effect of the meal, as nearly no
additional insulin injection was needed after meal intake.
For the slow meals, a second insulin injection was necessary
between 1 and 4 hours after the meal intakes. The shapes of
the BG predictions and measurements were similar, for the
fast as well as for the slow meals.
Table I gives the values of the objective function Jopt for
the two blocks. Except for the couple (patient 1, fast meal),
the optimized insulin profiles led to significant reductions of
Jopt. These reductions are particularly important for the slow
meals. The insulin infused between 1 hour and 4 hours after
the intake of the slow meals prevents from the hyperglycemia
that was observed during the first blocks.
For the couple (patient 1, fast meal), the BG excursion
measured at the first block was close to the target profile
except for a hypoglycemic event that occurred 4-5 hours after
the meal intake. To avoid this, the optimization recommended
a smaller insulin infusion. However, this correction was too
important and led to a higher value for Jopt.
As already mentioned, the BG model predictions for the
second block (plain blue line) exhibit shapes in accordance
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TABLE I
VALUES OF Jopt FOR THE 1st AND 2nd BLOCK AND THEIR RELATIVE
VARIATION. BG MEASUREMENTS AFTER HYPOGLYCEMIA EVENTS WERE
NOT TAKEN INTO ACCOUNT FOR THE COMPUTATION OF Jopt .
Standard Optimized Relative
1st block 2nd block variation
Patient 1 fast meal 4776 7921 +65.89%
Patient 1 slow meal 19323 6000 -69.95%
Patient 2 fast meal 24440 12143 -50.31%
Patient 2 slow meal 36874 10858 -70.55%
with the expected BG excursions (dotted blue line). However,
it should also be noted that the optimization procedure led
to too aggressive corrections between the 2 blocks. The size
of the different boluses can be found in Table II. As seen,
they differ significantly.
Obviously, the model is not able to predict BG with
a good confidence when the insulin profile used for the
identification differs too much from the insulin profile used
for the computation of the predictions. The limitations of
the predictions capabilities of the model can have different
reasons, some of them are listed below:
• The choice of the model structure was mainly driven by
the identifiability of the parameters and by the accuracy
of the fits. It is known that glucagon, free fatty acids
or growth hormones, as well as many other molecules,
influence the BG. They have been intentionally ne-
glected, as it would have been impossible to quantify
their contribution with only a few BG measurements.
Therefore, the model used for this implementation is
an oversimplification of the glucose metabolism. This is
the main reason for the limited prediction capabilities.
• The model parameters for a couple (P,A) were identified
on a single dataset collected during the first block.
As mentioned earlier, several disturbances like stress,
physical activity or menstrual cycles have not been con-
sidered. These disturbances should, at least, be filtered
TABLE II
TOTAL INFUSED INSULIN (U)
Standard Optimized
Patient 1 fast meal 6.1 3.3
Patient 1 slow meal 6.1 18.7
Patient 2 fast meal 4.7 6.1
Patient 2 slow meal 4.7 16.4
to minimize their influence on the model parameters
identified. This could be done, e.g., by using more than
one dataset to identify the parameters for a couple (P,A).
• Insulin absorption exhibits nonlinearities with respect
to the amount of injected insulin. However, the model
used in this work is linear. Therefore, the identified
parameters should not be used to compute predictions
for insulin infusion profiles that differ too much from
the profiles used for the identification.
• Physiological parameters of a PwD change over time.
As the second block was performed approximately 2
months after the first one, the identified model param-
eters may not be accurate enough anymore.
IV. CONCLUSION AND OUTLOOK
The results presented in this paper are promising. An
optimized distributed insulin profile led to a reduced BG
peak after a fast meal intake. It also corrected for the
hyperglycemic events observed during the first block a few
hours after the slow meal intakes. However, corrections were
shown to be potentially aggressive and future work should
include the following improvements:
• Small step strategy: The difference between two con-
secutive insulin profiles for the same meal should be
penalized in Jopt, as proposed in [12]. Indeed, the pre-
liminary clinical results have shown that the extrapola-
tion capabilities of the model are too limited to allow big
variations between two consecutive insulin profiles. By
introducing this penalty term in Jopt, several iterations
will be necessary to converge to an optimal insulin
profile for a couple (P, A), but safety will be improved.
• No meal-dependent target profile: The proposed ap-
proach requires meal-dependent target BG profiles as
shown in Fig. 6. It assumes that some a priori knowl-
edge is available on the absorption dynamics of each
meal. In practice, this is very difficult to conceive.
Instead, a constant target profile could be used for all
of the meals and a new objective function Jopt should
be used. This new Jopt would penalize deviation from
target in an asymmetrical manner. BGs below target
would have a much stronger contribution to Jopt than
BGs above target to avoid hypoglycemia. An objective
function ins red by the metric defined in [13] could be
used advantageously.
• Robust identification: Some of the model parameters
(Kx, ax, Sg,zero, and Uendo) do not depend on the meal
but only on the patient. In this paper, all the parameters
are identified for each couple (P, A). Results could be
improved if the patient dependent parameters would be
identified using datasets from different meals.
• Learning horizon reduction: The learning horizon
should be reduced to 4h for practical reasons. Indeed,the
time between two consecutive meal intakes is frequently
smaller than 6h.
However, the main limitation of the proposed approach lies
in the simplicity of the model used for optimization. This
is clearly an advantage for identification, which is made
possible on the basis of sole glucose measurements, but
meanwhile it can be a drawback at the optimization stage.
To be able to predict the real optimal insulin profiles for
a given patient, the tendency model we are using should
fulfill some adequacy requirements [14]. In practice, these
requirements are hard to meet, but future research should
compare the accuracy of this simplified model with more
complex models (for example [9], [15]). Also, to avoid
hyper- or hypoglycemia, robust optimization (i.e. optimiza-
tion considering uncertainty, e.g. deduced from confidence
intervals) should be investigated.
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APPENDIX
A. Maximum A Posteriori identification strategy: Transfor-
mation
In the Maximum A Posteriori method, the vector θ of
model parameters is a random variable. In this paper, this
random variable is assumed to have a log-normal distribution.
This distribution is widely used in the context of physiolog-
ical model parameters as it ensures that any realization of
this random variable will have a positive value.
By definition we have:
θi = exp(Θ)i for each i ∈ {1, · · · , Nθ}, (9)
with Nθ = dim(θ), and Θ = [Θ1, · · · ,ΘNθ ] is a random
vector having a multivariate normal distribution. Θ is thus
fully defined by a mean vector µΘ and a covariance matrix
ΣΘ with:
µΘ = E[Θ] (10)
ΣΘ = E[(Θ− E[Θ])(Θ− E[Θ])T ], (11)
with the autocorrelation coefficients being:
σΘ(i) =
√
ΣΘ(i, i), (12)
and the correlation coefficients:
σΘ(i, j) =
ΣΘ(i, j)
σΘiσΘj
. (13)
A transformation that defines a one-to-one relationship
between Θ and a vector M of uncorrelated normalized (zero
mean and identity covariance) Gaussian vector is applied.M
is also of dimension Nθ.
This transformation is defined as follows:
Θ = AM +B, (14)
where A is called the transformation matrix.
A and B should be uniquely defined by µΘ and ΣΘ. To
determine the relationship between these three entities, first
the mean of Θ is computed as follows:
E[Θ] = AE[M ] +B. (15)
M has zero mean. Thus:
E[Θ] = µΘ = B. (16)
The covariance of Θ is computed:
ΣΘ = E[(Θ− E[Θ])(Θ− E[Θ])T ]. (17)
Θ = AM +B and E[Θ] = B, thus:
ΣΘ = E[(AM)(AM)
T ]. (18)
Developing:
ΣΘ = E[AMM
TAT ] = AE[MMT ]AT . (19)
However E[MMT ] is the identity matrix, remembering
that M is a set of independent normalized Gaussian vari-
ables. Thus, we have:
ΣΘ = AA
T . (20)
If A is chosen as a triangular matrix, it can easily be
proven that the components A(i, j) of the matrix A are
defined by the two following equations:
A(j, j) =
√√√√σΘ(j)2 − j−1∑
k=1
A(j, k)2 (21)
A(i, j) =
σΘ(j)σΘ(i)σΘ(j, i)−
∑j−1
k=1 (A(j, k)A(i, k))
A(j, j)
.
(22)
A and B are now fully defined. As a reminder, we have:
θ = exp(Θ) = exp(AM +B). (23)
B. Maximum A Posteriori identification strategy: Objective
function
The minimized objective function for the parameter iden-
tification takes the following form:
Jid =
Ng∑
i=1

(
Gˆ(ti,M)−G(ti)
)2
σ2i
+ Nθ∑
j=1
M2j ,
where Ng is the total number of glucose measurements used
for the identification and Nθ is the number of parameters
being identified. Mj are the corresponding Nθ normalized
Gaussian variables which together are the previously men-
tioned M vector.
